For individuals with pre-existing gastrointestinal conditions such as inflammatory bowel disease, previous bowel surgery, or chronic constipation, closer monitoring may be warranted when initiating therapy
Research in obese mice showed AOD-9604 restored suppressed beta-3 receptor expression to levels seen in lean animals
Ethics declarations Disclosure Avery Brown, Helena Sergent, Alexander Hien Vu, Helen Liu, Jason Fisher, Eduardo Somoza, Tony Mei, Jeffrey Lipman, Julia Park, Patricia Chui, John Saunders, Marina Kurian, Loic Tchokouani, George Ferzli, Christine Ren-Fielding, Manish Parikh, Megan Jenkins have no conflicts of interest or financial ties to disclose
Any marketing suggesting FDA approval or endorsement for this product is misleading
4.3 Dual GIP/GLP-1 receptor agonists The unimolecular dual incretin receptor agonist offers a more physiological approach to managing diseases associated with T2DM compared to GLP-1RAs alone